Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
ACA, adequacy, affirm, Anderson, anemia, API, atezolizumab, Bay, Biotech, bladder, Boehringer, buying, catalyze, center, Century, certify, classical, COBRA, Colony, constantly, constraint, creation, debilitating, deliverable, deplete, disaggregation, District, DOC, domestic, domestically, Eli, excise, expiry, explicit, fast, FCPA, fifteen, fourteen, gBRCA, GPO, Hodgkin, implicit, Ingelheim, input, interdependent, internationally, interrelated, IRC, Janssen, JJDC, Johnson, justify, Kavita, lab, Lilly, MD, MDACC, mid, mix, Moonshot, myChoice, neck, negligible, NIH, Nonmonetary, nurse, output, page, passage, Patel, permanently, perspective, petition, preapproved, proof, Pty, qualification, recurrent, referendum, Regeneron, repeal, repealed, resubmission, rolling, RUBRACATM, salary, satisfactory, Science, Shanghai, Shield, shipment, speed, stability, stimulate, sum, taxation, TECENTRIQ, timeline, TOPACIO, Trump, undermine, underpayment, underutilization, undistributed, University, unpatentability, unrealized, upheld, USPTO, VSOE, withholding, workforce, Zai, Zug
Removed:
Africa, ALK, Alliance, Amgen, anaplastic, ascending, ASCO, Australia, bioequivalence, Canada, capable, categorize, CFO, chain, colorectal, Commonwealth, compromising, cough, deploying, divestiture, dramatically, efficient, emerging, enrich, Ewing, faster, figure, foundation, GlaxoSmithKline, Guard, hydrochloride, Ideally, immunization, India, inhibited, institution, isolated, isolation, jointly, journal, kinase, learn, linear, matured, MGI, mice, micelle, minimize, modulation, monohydrate, month, mutated, newly, organizing, path, payroll, penetration, personalized, pharma, pharmacodynamic, polymorphic, PONV, positioned, progressing, PTO, pure, pursued, radiosensitivity, radiotherapy, reach, reclassified, recombinant, relying, representing, rescue, resistant, Russia, Sanofi, SARC, sarcoma, score, screening, Secretary, selecting, selection, sensitized, sister, staffing, Suite, supported, Teva, threatening, toxic, toxicity, transformational, Treasurer, upfront, vivo, warrant, xenograft, Zealand
Filing tables
Filing exhibits
- 10-K Annual report
- 10.15 EX-10.15
- 10.16 EX-10.16
- 10.17 EX-10.17
- 10.25 EX-10.25
- 10.26 EX-10.26
- 10.36 EX-10.36
- 10.37 EX-10.37
- 10.38 EX-10.38
- 10.39 EX-10.39
- 10.40 EX-10.40
- 10.8 EX-10.8
- 12.1 EX-12.1
- 21.1 EX-21.1
- 23.1 EX-23.1
- 31.1 EX-31.1
- 31.2 EX-31.2
- 32.1 EX-32.1
- 32.2 EX-32.2
- Download Excel data file
- View Excel data file
Related press release
TSRO similar filings
Filing view
External links